March 27, 2019
Hilton Vienna Danube Waterfront
Vienna, Austria

This event is over, check out our other events

ABOUT CHINA FOCUS@EUROPE VIENNA

Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened the door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.

China Focus @ Europe Vienna is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior to and during the forum.

Mar 27, 2019 Hilton Vienna Danube Waterfront Vienna, Austria

ATTENDEE DEMOGRAPHICS

at Previous China Focus Events

Attendees

European Countries

Executive Level Attendees

Chinese Companies and Investors

One-to-one meetings

Company Presentations

WHAT

EXPECT

AGENDA

Plenary session: Grand Waterfront Hall 1

8:00 – 9:00	Check-in
9:00 – 9:10	Opening Remarks
9:10 – 9:40	Keynote: Status and trends of Chinese investment in Europe Csaba Wolf – Business Development Director, Deloitte
9:40 – 10:30	PANEL 1: Opportunities and challenges with China-Europe partnership in life science and healthcare Andy Li – Founding Partner, BioSense Global LLC Dong Chen – Director and China head of business development, Jiangsu Hengrui Pharmaceutical Katherine Cohen – Venture Partner, Panacea Venture Olivier Reinhard – VP Head of business development transactions for China and Emerging Markets, Sanofi
10:30 – 10:40	Break
10:40 – 11:10	Cross-border Camp Talk: Strategic considerations for obtaining patents on your intellectual property assets Daniel J. Nevrivy – Founder, Nevrivy Patent Law Group P.L.L.C.
11:10 – 12:00	PANEL 2: European innovations meet China resources Aamir Shahzad – President, European Society for Translational Medicine Dianna Qian – Partner, Pivotal bioVenture Partners China Fei Tian – Principle, Vesalius Biocapital Gottfried Köhler – Chair of Advisory Board, European Society for Translational Medicine James Warr – Associate, Greenhill & Co.
12:00 – 13:30	Lunch
13:30 – 14:20	PANEL 3: Oversea strategies of Chinese innovative biotech & pharma Tom Du – Medical Partner, Shenzhen Share Capital Jun Bao – President and CEO, Impact Therapeutics Qingping Zeng – President and CEO, Fosun Orinove Ping Cao – VP business development, Henlius Biotech Sara Chen – Head of business development, Genfleet Therapeutics
14:20 – 15:30	Company Presentation
15:30 – 15:40	Break
15:40 – 16:10	Cross-border Camp Talk: Valuation of your licensing asset – deal or no deal Patrik Frei – CEO, Venture Valuation AG
16:10- 17:00	PANEL 4: Partnering opportunities with Chinese pharma Echo Hindle-Yang – CEO, MSQ Ventures Qun Dang – VP Global head of business development, Qilu Pharmaceutical John Xu – CEO and co-founder, Jemincare Therapeutics Carlos de Sousa – CEO, Immunicum AB
18:00 – 20:00	MyBioGate China Focus Dinner (Separate registration required)